Morphine Completed Phase 4 Trials for Dyspnea / Morphine / Interstitial Lung Disease (ILD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02622022Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease
NCT02067338Epidural Low Dose Morphine in Postoperative Pain After Posterior Lumbar Spinal Surgery